Jack W. Callicutt
Overview
Jack W. Callicutt received an average of $667K in total compensation, including $261K in salary, at Galectin Therapeutics from 2013 to 2023.
2023Galectin TherapeuticsChief Financial Officer
2022Galectin TherapeuticsChief Financial Officer
2021Galectin TherapeuticsChief Financial Officer
2020Galectin TherapeuticsChief Financial Officer
2019Galectin TherapeuticsChief Financial Officer
2018Galectin TherapeuticsChief Financial Officer
2017Galectin TherapeuticsChief Financial Officer
2016Galectin TherapeuticsChief Financial Officer
2015Galectin TherapeuticsChief Financial Officer
2014Galectin TherapeuticsChief Financial Officer
Source: SEC filings on December 3, 2024, October 6, 2023, October 17, 2022, October 19, 2020, April 11, 2018, November 7, 2017, and November 10, 2016.
Related executives
We found 11 more executives who work or worked at Galectin Therapeutics.
Joel Lewis
Galectin Therapeutics
Chief Executive Officer
Pol Boudes
Galectin Therapeutics
Chief Medical Officer
Harold Shlevin
Galectin Therapeutics
Chief Executive Officer
Peter Traber
Galectin Therapeutics
Chief Executive Officer
James Czirr
Galectin Therapeutics
Chairman
Maureen Foley
Galectin Therapeutics
Chief Operating Officer
Anthony Squeglia
Galectin Therapeutics
Chief Financial Officer
Theodore Zucconi
Galectin Therapeutics
Chief Executive Officer
News
Galectin Therapeutics CEO Joel Lewis' 2023 pay slips 1% to $964K
December 3, 2024
Galectin Therapeutics CEO Joel Lewis' 2022 pay slips 17% to $974K
October 6, 2023
Galectin Therapeutics CEO Joel Lewis' 2021 pay jumps 55% to $1.2M
October 17, 2022
Galectin Therapeutics CEO Harold Shlevin's 2019 pay falls 25% to $1.3M
October 19, 2020